A novel prognostic signature of immune‐related genes for patients with colorectal cancer

Jun Wang(Sun Yat-sen University), Jian Chen(Fudan University), Yi Huang(Children's Hospital of Chongqing Medical University), Lele Lin(Second Affiliated Hospital of Zhejiang University), Lie Wang(Zhejiang Chinese Medical University), Guofeng Chen(302 Military Hospital of China), Shaojun Yu(Second Affiliated Hospital of Zhejiang University), Dan Wu(Nanjing Drum Tower Hospital), Muxing Kang(Second Affiliated Hospital of Zhejiang University), Xiaoli Jin(Second Affiliated Hospital of Zhejiang University)
Journal of Cellular and Molecular Medicine
June 21, 2020
10.1111/jcmm.15443
Cited by 67

Related Papers

Detectable clonal mosaicism from birth to old age and its relationship to cancer
|Nature Genetics|2012|598
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome
|Oncotarget|2015|212
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma†
|Human Molecular Genetics|2011|201
TLR8 signaling enhances tumor immunity by preventing tumor‐induced T‐cell senescence
|EMBO Molecular Medicine|2014|165